Doral

Quazepam (marketed under brand names Doral, Dormalin) is a relatively long-acting benzodiazepine derivative drug developed by the Schering Corporation in the 1970s.[1] Quazepam is indicated for the treatment of insomnia including sleep induction and sleep maintenance.[2] Quazepam induces impairment of motor function and has relatively (and uniquely) selective hypnotic and anticonvulsant properties with considerably less overdose potential than other benzodiazep... [wikipedia]